Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biologics
Brought to you by:
Biotech
Caribou cuts 32% of staff, further purges cell therapy pipeline
The cuts are Caribou's second in less than a year, following another layoff round and the shuttering of an NK cell therapy program in July 2024.
Darren Incorvaia
Apr 24, 2025 9:55pm
NIH nixes financing for Pluri's radiation exposure cell therapy
Apr 18, 2025 9:10am
Verve posts clean PCSK9 editor profile, teeing up Lilly decision
Apr 14, 2025 7:00am
ADCs to cell therapy: How AZ aims to 'redefine' oncology
Apr 9, 2025 11:44am
Lexeo locks in pivotal trial plan as gene therapy data accrue
Apr 7, 2025 9:37am
Lilly saves gene therapy biotech with $18M upfront deal
Apr 3, 2025 6:00pm
